These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22120783)

  • 1. [Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome].
    Gustapane M; Cardillo MT; Biasillo G; Biasucci LM
    Recenti Prog Med; 2011 Nov; 102(11):447-50. PubMed ID: 22120783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.
    Loria V; Dato I; Graziani F; Biasucci LM
    Mediators Inflamm; 2008; 2008():135625. PubMed ID: 18382609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
    Sawicki M; Sypniewska G; Kozinski M; Gruszka M; Krintus M; Obonska K; Pilaczynska-Cemel M; Kubica J
    Eur J Clin Invest; 2011 Jun; 41(6):667-71. PubMed ID: 21226709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of myeloperoxidase in routine clinical practice.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):223-30. PubMed ID: 21453218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome].
    Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
    Ferrante G; Nakano M; Prati F; Niccoli G; Mallus MT; Ramazzotti V; Montone RA; Kolodgie FD; Virmani R; Crea F
    Circulation; 2010 Dec; 122(24):2505-13. PubMed ID: 21126969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase is not useful for the early assessment of patients with chest pain.
    Eggers KM; Dellborg M; Johnston N; Oldgren J; Swahn E; Venge P; Lindahl B
    Clin Biochem; 2010 Feb; 43(3):240-5. PubMed ID: 19822136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase and C-reactive protein in patients with cocaine-associated chest pain.
    O'Conor K; Chang AM; Wu AH; Hollander JE
    Am J Emerg Med; 2013 Apr; 31(4):664-9. PubMed ID: 23380098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter by Schindhelm regarding article, "High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".
    Schindhelm RK
    Circulation; 2011 Jul; 124(4):e143; author reply e144. PubMed ID: 21788597
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
    Emami Razavi A; Basati G; Varshosaz J; Abdi S
    Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
    Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S
    Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.
    Lee R
    Arch Med Res; 2011 Oct; 42(7):641. PubMed ID: 22000979
    [No Abstract]   [Full Text] [Related]  

  • 15. Response: myeloperoxidase as a biomarker in acute coronary syndrome: a trap or a treasure.
    Chen Y; Zhang F; Dong L; Shu X
    Arch Med Res; 2011 Oct; 42(7):642-3. PubMed ID: 22000978
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
    Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
    Stefanescu A; Braun S; Ndrepepa G; Koppara T; Pavaci H; Mehilli J; Schömig A; Kastrati A
    Am Heart J; 2008 Feb; 155(2):356-60. PubMed ID: 18215608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of biochemical marker detection in risk stratification in patients with acute coronary syndrome].
    Liu B; Fu Q; Yan QN; Jin W; Tao DP; Hua JH; Li ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1015-9. PubMed ID: 20501382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma myeloperoxidase levels in patients with acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Iliescu I; Botnaru L; Gurban CV; Sfrijan F; Tănăsescu R
    Rom J Intern Med; 2010; 48(1):101-4. PubMed ID: 21180247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.